Global Sialadenitis Market, By Type (Acute Sialadenitis, Chronic Sialadenitis, Granulomatous Sialadenitis), Treatment (Antibiotic, Surgery, Warm Compresses, Massage, Others), Diagnosis (Ultrasound, CT scan, MRI, Sialoendoscopy, Others), Route of Administration (Intravenous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Sialadenitis Market
Sialadenitis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4% in the above mentioned forecast period.
Sialadenitis is also known as sialoadenitis or salivary gland infection. It causes blockage in the saliva duct due to the inflammation which us caused by the bacteria or virus. It most commonly affects the parotid salivary glands on the side of the face, near the ear and submandibular salivary glands under the jaw. Pain, fever, chills, pus in mouth, skin redness, tenderness and swelling around the affected area are the symptoms of sialadenitis. It most commonly affects elderly and chronically ill especially the ones with the dry mouth or who are dehydrated.
Rise in the prevalence of sialadenitis and increasing incidence of lifestyle disorder such as diabetes, anorexia, rheumatoid arthritis and kidney failure. All these will reduce the flow of saliva and trigger the salivary gland infection, hence, driving the growth of sialadenitis market. Also, growing healthcare expenditure, rising incidence of smoking tobacco, alcohol abuse, upsurge in the chemotherapy or radiation therapy of mouth, head or neck and rising geriatric population are the factors that will expand the sialadenitis market.
Rise in the research and development activities and increase in the awareness about the preventive measures will provide beneficial opportunities for the sialadenitis market in the forecast period of 2021-2028.
However, high cost of treatment and complications associated with the infection such as formation of abscess, development of cutaneous fistula and localized spreading of bacterial infection are the factors that will hinder the market growth and will further challenge the sialadenitis market in the forecast period mentioned above.
This sialadenitis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sialadenitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Sialadenitis Market Scope and Market Size
The sialadenitis market is segmented on the basis of type, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the sialadenitis market is segmented into acute sialadenitis, chronic sialadenitis and granulomatous sialadenitis.
- On the basis of treatment, the sialadenitis market is segmented into antibiotic, surgery, warm compresses, massage and others.
- On the basis of diagnosis, the sialadenitis market is segmented into ultrasound, CT scan, MRI, sialoendoscopy and others.
- On the basis of route of administration, the sialadenitis market is segmented into intravenous and others.
- On the basis of end-users, the sialadenitis market is segmented into clinic, hospital and others.
The sialadenitis market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Sialadenitis Market Country Level Analysis
Sialadenitis market is analyzed and market size information is provided by the country, type, treatment, diagnosis, route of administration, end-users and distribution channel as referenced above.
The countries covered in the sialadenitis market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the sialadenitis market due to the presence of major key players, high disposable income, high healthcare expenditure and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Sialadenitis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Sialadenitis Market Share Analysis
Sialadenitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to sialadenitis market research.
The major players covered in the sialadenitis market report are Allergan, Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Tetraphase Pharmaceuticals, Paratek Pharmaceuticals, Inc., Nabriva Therapeutics plc, Spero Therapeutics, Abbott, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Lilly, Aurobindo Pharma, Lupin, SHIONOGI & Co., Ltd., AbbVie Inc., and Cumberland Pharmaceuticals Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-